ArticleThe Journal of clinical investigation2024

Anti-PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centers.

Karsten Eichholz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.